alpha-L-FucpNAc-(1->3)-alpha-D-GalpNAc-(1->4)-alpha-D-GalpO[CH2]5NH2

Term ID

CHEBI:134230

Synonyms

5-aminopentyl 2-acetamido-2,6-dideoxy-alpha-L-galactopyranosyl-(1->3)-2-acetamido-2-deoxy-alpha-D-galactopyranosyl-(1->4)-alpha-D-galactopyranoside
5-aminopentyl 2-acetamido-2-deoxy-alpha-L-fucopyranosyl-(1->3)-2-acetamido-2-deoxy-alpha-D-galactopyranosyl-(1->4)-alpha-D-galactopyranoside
5-aminopentyl N-acetyl-alpha-L-fucosaminyl-(1->3)-N-acetyl-alpha-D-galactosaminyl-(1->4)-alpha-D-galactoside
alpha-L-FucNAc-(1->3)-alpha-D-GalNAc-(1->4)-alpha-D-GalO[CH2]5NH2
FucNAcalpha1-3GalNAcalpha1-4GalO[CH2]5NH2

Definition

A linear trisaccharide derivative consisting of N-acetyl-alpha-L-fucosaminyl, N-acetyl-alpha-D-galactosaminyl and alpha-D-galactosyl residues linked sequentially (1->3) and (1->4), and at the reducing end linked glycosidically to a 5-aminopentyl group.

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: glycoside trisaccharide derivative

glycoside trisaccharide derivative Show first 5 Terms

Phenotype

Phenotype resulting from alpha-L-FucpNAc-(1->3)-alpha-D-GalpNAc-(1->4)-alpha-D-GalpO[CH2]5NH2

Phenotype where environments contain alpha-L-FucpNAc-(1->3)-alpha-D-GalpNAc-(1->4)-alpha-D-GalpO[CH2]5NH2

Phenotype modified by environments containing alpha-L-FucpNAc-(1->3)-alpha-D-GalpNAc-(1->4)-alpha-D-GalpO[CH2]5NH2

Human Disease Model